Page last updated: 2024-10-29
avapro and Depression
avapro has been researched along with Depression in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Yang, Q | 1 |
| Yu, J | 1 |
| Qin, H | 1 |
| Liu, L | 1 |
| Di, C | 1 |
| Zhuang, Q | 1 |
| Yin, H | 1 |
Other Studies
1 other study available for avapro and Depression
| Article | Year |
|---|---|
Irbesartan suppresses lipopolysaccharide (LPS)-induced blood-brain barrier (BBB) dysfunction by inhibiting the activation of MLCK/MLC.
Topics: Actomyosin; Animals; Behavior, Animal; Blood-Brain Barrier; Capillary Permeability; Cell Line; Depre | 2021 |